Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TriplePoint Venture Growth BDC is a publicly traded, externally managed business development company that provides customized debt financing, equipment financings, revolving loans, warrants, and selective direct equity investments to venture-backed growth-stage companies. The company operates as the primary public vehicle for the venture growth business of its sponsor, TriplePoint Capital, and focuses mainly on technology and other high-growth sectors, with exposure that can include life sciences. It is not a drug developer, biotech operating company, CRO, or CDMO; rather, it is a specialty finance platform serving venture-backed businesses. For healthcare and life sciences analysts, the company is best understood as a capital provider to companies in those sectors rather than a therapeutic product company with its own clinical pipeline. Its income is generated primarily from interest and fee-bearing credit investments rather than sales of healthcare products or services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TriplePoint Venture Growth BDC.